ReleaseWire Connect

DelveInsight's, mGlu2 Antagonists- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the mGlu2 Antagonists. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The mGlu2 Antagonists Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage.

Jewelry, Watches and Accessories Retailing in China - Market Summary & Forecasts provides a detailed analysis of both the historic and forecast market data of jewelry, watches and accessories retail sales across key channels in China.

DelveInsight's, IL-1 Receptor Antagonists- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the IL-1 Receptor Antagonists. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The IL-1 Receptor Antagonists Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage.

DelveInsight's, Matrix Metalloproteinase 9 (MMP-9) Inhibitors- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Matrix Metalloproteinase 9 (MMP-9) Inhibitors. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Matrix Metalloproteinase 9 (MMP-9) Inhibitors Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage.

DelveInsight's, CCR2 Inhibitors- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the CCR2 Inhibitors. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The CCR2 Inhibitors Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage.

DelveInsight's, Thioredoxin Reductase Inhibitors- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Thioredoxin Reductase Inhibitors. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Thioredoxin Reductase Inhibitors Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage.

DelveInsight's, 5-HT1B Agonists- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the 5-HT1B Agonists. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The 5-HT1B Agonists Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage.

DelveInsight's, Anaplastic Lymphoma Kinase (ALK) Inhibitors- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Anaplastic Lymphoma Kinase (ALK) Inhibitors. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Anaplastic Lymphoma Kinase (ALK) Inhibitors Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage.

DelveInsight's, P2Y12 Platelet ADP Receptor Antagonists- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the P2Y12 Platelet ADP Receptor Antagonists. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The P2Y12 Platelet ADP Receptor Antagonists Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage.

DelveInsight's, Inhibitors of Apoptosis (IAP) Antagonists- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Inhibitors of Apoptosis (IAP) Antagonists. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Inhibitors of Apoptosis (IAP) Antagonists Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage.